×
Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression PDF
$ 40.00
Psychotic Features in Patients With Major Depressive Disorder: A Report From the European Group for the Study of Resistant Depression PDF quantity
$ 40.00
×
Inflammation and the Phenomenology, Pathophysiology, Comorbidity, and Treatment of Bipolar Disorder: A Systematic Review of the Literature PDF
$ 40.00
Inflammation and the Phenomenology, Pathophysiology, Comorbidity, and Treatment of Bipolar Disorder: A Systematic Review of the Literature PDF quantity
$ 40.00
×
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of Adjunctive Aripiprazole for Schizophrenia or Schizoaffective Disorder Inadequately Treated With Quetiapine or Risperidone Monotherapy PDF
$ 40.00
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 16-Week Study of Adjunctive Aripiprazole for Schizophrenia or Schizoaffective Disorder Inadequately Treated With Quetiapine or Risperidone Monotherapy PDF quantity
$ 40.00
×
Two-Year Follow-Up of a Smoking Cessation Trial in Patients With Schizophrenia: Increased Rates of Smoking Cessation and Reduction. PDF
$ 40.00
Two-Year Follow-Up of a Smoking Cessation Trial in Patients With Schizophrenia: Increased Rates of Smoking Cessation and Reduction. PDF quantity
$ 40.00
×
Agomelatine Prevents Relapse in Generalized Anxiety Disorder: A 6-Month Randomized, Double-Blind, Placebo-Controlled Discontinuation Study PDF
$ 40.00
Agomelatine Prevents Relapse in Generalized Anxiety Disorder: A 6-Month Randomized, Double-Blind, Placebo-Controlled Discontinuation Study PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart
